Page 20 - Translational Sciences News Today

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

Gene therapy advocates say the treatments can cure rare diseases more quickly if government helps.

This study examines the incidence of and risk factors for venous and arterial thrombosis in patients hospitalized with COVID-19 in 4 New York City hospitals.

Years in the making, the atlas identifies 1.2 million “injury neighborhoods,” which could help uncover the causes of kidney disease.

Los Angeles, California, July 18, 2023 (GLOBE NEWSWIRE) -- The Lundquist Institute and Advent Therapeutics have announced a landmark collaboration that has resulted in a significant $3 million Small Business

FRIDAY, July 7, 2023 (HealthDay News) -- The use of antipsychotic medication in children is continuing to plummet, likely because of better policies and education, new research shows.

Two drugs commonly used to treat inflammatory diseases such as rheumatoid arthritis and psoriasis did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared with standard care alone, according to a study led by the Washington University School of Medicine in St. Louis.

Whole genome scans took longer than a commercially available test, but not for most urgent cases

Two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19, according to a national study led by Washington University School of Medicine in St. Louis. William G. Powderly, MD, (right) who led the large clinical trial, discusses patient conditions with Maanasi Samant, MD, in the intensive care unit at Barnes-Jewish Hospital, one of the major trial sites, during the COVID-19 pandemic.

This study reports the results of 3 randomized, double-masked, placebo-controlled substudies of abatacept, cenicriviroc, and infliximab plus standard care for C